NL-OMON48060已完成不适用
Health testing with all subjects who participated in any phase I clinical study and received at least one dose of HTL0018318/AGN-242071 to date. - HTL0018318/AGN-242071 Health Testing Programme
Heptares Therapeutics Ltd.0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All subjects who received at least one dose of active study medication in any prior HTL0018318/AGN-242071 clinical study.
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A study in healthy volunteers to look at how different formulations (recipes) of the test medicine firibastat (QGC001) are taken up and broken down by the bodyISRCTN24120533Quantum Genomics (France)30
招募中
不适用
Cohort research using a health check systemOphthalmological and vascular diseasesJPRN-UMIN000047201Seirei Hamamatsu Genearl Hospital1,000,000
撤回
不适用
A study in healthy volunteers to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of BN201, an investigational compound for the treatment of acute optic neuritis.inflammation of the optic nerve.10030061NL-OMON42731Bionure Pharma S.L. Barcelona32
尚未招募
不适用
A pilot study of healthy volunteers to compare the performance of standard nasal oxygen cannula at high flows with the Optiflow” high flow nasal oxygen (HFNO) system.ACTRN12618001367235Fiona Stanley Hospital30
招募中
Unknown
Cohort study to discover unmet health care needs of gastric cancer survivorsKCT0008810ational Cancer Center1,684